Published on: September 5, 2022

Largest ever contract validates growth strategy

Instem has signed its largest ever single contract, a five-year $12m deal with a leading global contract research organisation (CRO). The group is deploying its new Aspire clinical trial acceleration solution to over 2,000 users worldwide. In our view, the contract win validates the group’s growth strategy and further demonstrates Instem’s inherent M&A ability. We leave forecasts unchanged following this positive news, anticipating that the deal will underpin our future projections.

Related Content